期刊簡介預計審稿時間：

The GaBI Journal Generics and Biosimilars Initiative Journal (GABI J) is an academic journal dedicated to the field of generic drugs and biosimilars. This journal is committed to promoting the research, development, and application of generic drugs and biosimilars, providing an important communication platform for academia and industry.

GABI J is published or managed by Pro Pharma Communications International and is located in Belgium. This journal has been included in authoritative databases such as Emerging Sources Citation Index (ESCI), demonstrating its significant influence in the fields of generic drugs and biosimilars. At the same time, GABI J also provides paper editing, translation, typesetting and other services through platforms such as LetPub, helping global authors publish high-quality research papers smoothly.

《Gabi 期刊-仿制藥和生物仿制藥倡議期刊》（簡稱GABI J）是一本專注于仿制藥（Generics）和生物類似藥（Biosimilars）領域的學術期刊。該期刊致力于推動仿制藥和生物類似藥的研究、開發與應用，為學術界和產業界提供了一個重要的交流平臺。

GABI J由Pro Pharma Communications International出版或管理，出版地位于比利時（Belgium）。該期刊被Emerging Sources Citation Index (ESCI)等權威數據庫收錄，顯示出其在仿制藥和生物類似藥領域的一定影響力。同時，GABI J還通過LetPub等平臺提供論文編輯、翻譯、排版等服務，助力全球作者順利發表高質量的研究論文。

如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。